Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Zetia & Vytorin case study' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Winning Product Launch Strategies Maximizing sales from new pharmaceutical products |
April 2007 | £1495 | 35 % |
|
Launching Combination Products Brand Extension and Franchise Development Strategies |
January 2008 | £1995 | 33.6 % |
|
Commercial Insight: Antidyslipidemics Branded statins beware, generics are amongst you |
July 2006 | £8440 | 23.8 % |
|
Commercial Insight: Antidyslipidemics The competitive cost-conscious antidyslipidemics market presents challenges |
July 2007 | £7600 | 23.1 % |
|
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth |
October 2008 | £8000 | 22.4 % |
|
Launch Strategies - Analyzing Market Trends and Regulatory Impacts |
August 2007 | £8010 | 14.7 % |
